Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Robin Kate KelleyRebecca MiksadIrfan CicinYenHsun ChenHeinz-Josef KlümpenStefano KimZhong-Zhe LinJillian YoukstetterSaswati HazraSuvajit SenAnn-Lii ChengAnthony B El-KhoueiryTim MeyerGhassan K Abou-AlfaPublished in: British journal of cancer (2021)
ClinicalTrials.gov number, NCT01908426.
Keyphrases